Changes in UK drug-pricing scheme could impede access, group warns

05/8/2013 | PharmaTimes (U.K.)

A U.K. government proposal to use value-based pricing for pharmaceuticals could make it more difficult for patients to afford treatment, think tank 2020health says in a new report. The group calls for allowing drug companies to set their own prices and adjust old drug prices to ensure affordability.

View Full Article in:

PharmaTimes (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ